Access cutting-edge thyroid cancer treatment through this clinical trial at a research site in Allentown. Study-provided care at no cost to qualified participants.
Access thyroid cancer specialists in Allentown at no cost
This study follows strict safety protocols and ethical guidelines
All study-related thyroid cancer treatment provided free
The researchers are doing this study to find out if the combination of avutometinib and defactinib is an effective treatment for RAF dimer-driven radioiodine-refractory differentiated thyroid cancer or anaplastic thyroid cancer. The researchers will also test whether avutometinib and defactinib is a safe treatment that causes few or mild side effects.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this thyroid cancer clinical trial in Allentown, PA
If you're searching for thyroid cancer treatment options in Allentown, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Allentown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thyroid cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.